Intech Investment Management LLC Grows Stock Position in HCA Healthcare, Inc. $HCA

Key Points

• Intech Investment Management increased its HCA Healthcare stake by 10% in the fourth quarter, bringing its holdings to 55,273 shares worth about $25.8 million.
• Several other large institutional investors also boosted positions, and 62.73% of HCA stock is held by hedge funds and other institutional investors.
• Analysts remain generally positive despite recent cuts to price targets: HCA has a “Moderate Buy” consensus rating and a consensus price target of $515.77.

Intech Investment Management LLC increased its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 10.0% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 55,273 shares of the company's stock after purchasing an additional 5,019 shares during the quarter. Intech Investment Management LLC's holdings in HCA Healthcare were worth $25,805,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in the stock. Capital World Investors grew its position in shares of HCA Healthcare by 3.8% in the third quarter. Capital World Investors now owns 4,959,336 shares of the company's stock valued at $2,113,662,000 after purchasing an additional 179,443 shares in the last quarter. Geode Capital Management LLC grew its position in shares of HCA Healthcare by 0.4% in the fourth quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company's stock valued at $1,702,738,000 after purchasing an additional 13,565 shares in the last quarter. Arrowstreet Capital Limited Partnership grew its position in shares of HCA Healthcare by 1.8% in the third quarter. Arrowstreet Capital Limited Partnership now owns 2,065,225 shares of the company's stock valued at $880,199,000 after purchasing an additional 36,414 shares in the last quarter. Viking Global Investors LP grew its position in shares of HCA Healthcare by 58.5% in the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company's stock valued at $717,214,000 after purchasing an additional 690,773 shares in the last quarter. Finally, Legal & General Group Plc grew its position in HCA Healthcare by 0.8% during the third quarter. Legal & General Group Plc now owns 1,124,511 shares of the company's stock worth $479,267,000 after buying an additional 8,478 shares in the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

HCA has been the subject of several recent analyst reports. Leerink Partners reduced their target price on HCA Healthcare from $573.00 to $500.00 and set an "outperform" rating for the company in a research report on Monday, April 27th. Royal Bank Of Canada reduced their target price on HCA Healthcare from $593.00 to $534.00 and set an "outperform" rating for the company in a research report on Monday, April 27th. KeyCorp reduced their target price on HCA Healthcare from $550.00 to $510.00 and set an "overweight" rating for the company in a research report on Monday, April 27th. Wells Fargo & Company reduced their target price on HCA Healthcare from $481.00 to $436.00 and set an "equal weight" rating for the company in a research report on Monday, April 27th. Finally, JPMorgan Chase & Co. dropped their price target on HCA Healthcare from $535.00 to $490.00 and set a "neutral" rating for the company in a research note on Tuesday, May 19th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, HCA Healthcare currently has a consensus rating of "Moderate Buy" and a consensus target price of $515.77.

HCA Healthcare Trading Down 2.1%

NYSE HCA opened at $384.01 on Friday. HCA Healthcare, Inc. has a 1-year low of $330.00 and a 1-year high of $556.52. The stock has a 50-day moving average of $454.43 and a 200-day moving average of $481.46. The firm has a market cap of $85.19 billion, a PE ratio of 13.21, a price-to-earnings-growth ratio of 1.24 and a beta of 1.18.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts' consensus estimates of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company had revenue of $19.11 billion during the quarter, compared to the consensus estimate of $19.09 billion. During the same period last year, the firm posted $6.45 EPS. The company's revenue was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, equities research analysts forecast that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be issued a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare's payout ratio is currently 10.73%.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.